已收盘 06-16 16:00:00 美东时间
0.000
0.00%
Recursion appoints Fred Hassan as Board Chair, effective October 31, 2026. Hassan, with over 40 years in pharma, has a proven track record of transforming companies like Schering-Plough and BridgeBio Pharma. His leadership is expected to drive Recursion's AI-enabled drug discovery from clinical proof to patient impact.
11-02 21:05
欧洲生物技术公司Argenx计划在今年夏天发布关键的药物试验数据。该公司正受到大型制药公司密切关注。
2023-05-17 21:42